Vantive unveils latest in scientific support and innovation to advance lifesaving critical therapies for patients in intensive care
Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, showcased new clinical evidence in support of Extracorporeal Blood Purification at the 6th Asia Pacific Acute Kidney Injury & Continuous Renal Replacement Therapy Conference 2025 in Bangkok (APAC AKI CRRT Conference 2025). Vantive as sponsor for a consensus paper for Extracorporeal Blood Purification and a separate study of patients in the intensive care setting, joined with the clinical community at APAC AKI CRRT Conference 2025, announced the clinical support and showcased the company’s innovation in CRRT and multi-organ support. Developed by a group of Asia-Pacific experts, the two papers offer a perspective of sepsis and hyperinflammatory conditions; challenges that are also pressing concerns for Malaysian ICUs equip clinicians with capabilities needed to act decisively in the critical care setting. Prof. Nattachai Srisawat, MD, PhD Professor Nattachai Srisawat, MD, PhD from Thai...